eeking to restrain drug prices, the American Medical Association passed a resolution that would require drug makers to disclose pricing in ads that are aimed at consumers.

The proposal, which was approved by AMA delegates at their annual meeting in Chicago, came in response to concerns over rising drug costs and an unsuccessful bid by the medical organization to convince Congress to ban so-called direct-to-consumer advertising altogether.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Would it be too much to ask to have companies present the justification for their pricing to an advisory board for the FDA. I think it would help just to get these discussions into the light of day and out of the board room. Pharma will not stop maximizing profits if we ask them nicely, they must be compelled to do so.

  • Useless grandstanding. What price? List price? Net price (after rebates)? Patient copay? GoodRx price?

    Physician salaries in the US are 2-4X times what physician salaries in the EU are. Funny that the AMA never complains of an urgent need to solve the problem of excess compensation.

    • Hi Adam

      Thanks for the note. The resolution (link is in the post) says manufacturer’s suggested retail price. There’s no further detail or definition, unfortunately. I asked.

      Hope this helps,

    • Physicians at AMA should read this article: There’s No Magical Savings in Showing Prices to Doctors (https://www.nytimes.com/2017/06/12/upshot/theres-no-magical-savings-in-showing-prices-to-doctors.html)

      The retail price is often a poor measure of a drug’s true cost to the patient, the patient’s plan, and the healthcare system.

      Well at least the AMA can feel smug while conveniently deflecting attention from the biggest sources of healthcare spending (doctors and hospitals)!

  • Odd position to take – “More important, he argued, the proposal may violate the First Amendment. ” since when is adding information a ban .. uh, restriction – and why are prices political speech? OK, well lately but not usually?

  • Ed, that will happen the same day that doctors are required to post their prices on their ads. Even the snake oil salesmen told you up front that a bottle of Dr Shadrack Bennington’s Beneficent Balm will cost a buck and will cure whatever ails you.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy